I have found myself recommending this approach more often in recent years. Last week I spoke with a client who was considering buying several bioreactors and was torn between new and used. I suggested they call Camber Road and explore a lease.
https://t.co/048Fu9Qj8G
Most discussions about morale focus on motivation.
In my experience, morale problems are often confidence problems.
Teams lose confidence when they can no longer connect effort with outcome
👇
https://t.co/jW3tMgrQxR
Scaling in biotech is hard. The cost of putting steel in the ground is high. Some companies have considered repurposing existing infrastructure. It makes sense but has its own challenges.
https://t.co/b7M3342nSE
Having helped companies working on the gut microbiome/cancer therapeutic relationship, I am excited to see the field moving from correlations to mechanisms.
https://t.co/JjgaKc2Mp9
Most R&D roadmaps don’t fail because the science is wrong. They fail because the work isn’t aligned to what the company actually needs next.
https://t.co/Oq6nFlhrJ6